STABLEBODY TECHNOLOGIES LLC (“SBT”) is a protein engineering and protein reagent development company based in Madison, Wisconsin and founded in 2009. Protein engineering involves the re-design and modification of proteins to make the proteins work better in particular applications.

SBT has developed trade secret methods utilizing proprietary algorithms and databases, coupled with machine learning methods to more efficiently re-design and modify proteins for research, diagnostic, and therapeutic applications.

SBT is involved in the product manufacturing of the protein CD45, which is one of the most highly used products in the BioMedical world of proteins used.

SBT designs proteins that will perform better and be more thermally stable with similar or increased affinity. An example of this is its contract success with The United States Defense Department in which SBT successfully converted the storage requirements for bio-terror antidote reagents eliminating freezer storage requirements and allowing for room temperature or outdoor ambient storage temperatures. (e.g., increased thermal stability from 131F to 171F). Another dynamic market for SBT’s thermal stability and affinity data engineering is a client who would then be able to ship their manufactured product without refrigeration during shipping.

(A 25 μg sample can be provided to qualifying researchers.)